American Organ Transplant And Cancer Research Institute Llc

We track 2 ClinicalTrials.gov studies led by American Organ Transplant And Cancer Research Institute Llc. The portfolio skews toward Phase 2 (2 trials).

2 clinical trials sponsored by American Organ Transplant And Cancer Research Institute Llc.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 2
100%

Trial Status Breakdown

Trials by American Organ Transplant And Cancer Research Institute Llc

A Phase 1/2, Open-Label, Single-Arm Study to Evaluate the Safety, Immunogenicity Reduction, Transplant Function, and Feasibility of Ex Vivo CRISPR-Cas9 Gene-Edited Donor Liver Transplantation Targeting HLA Class I (HLA-A, HLA-B) and Class II (Via CIITA) Genes.

NCT07053488 · RECRUITING · Phase 2

Phase 1/2, Single-Arm, Open-Label Trial to Evaluate the Safety, Feasibility, and Immunogenicity of Ex Vivo CRISPR-Cas9 Gene-Edited Donor Kidneys (Knockout of HLA-A, HLA-B, and CIITA) in Human Renal Transplant Recipients

NCT07053462 · RECRUITING · Phase 2

Frequently Asked Questions

How many clinical trials does American Organ Transplant And Cancer Research Institute Llc sponsor?

American Organ Transplant And Cancer Research Institute Llc currently sponsors 2 clinical trials tracked on ReadTheTrial. These span Phase 2.

What conditions does American Organ Transplant And Cancer Research Institute Llc research?

American Organ Transplant And Cancer Research Institute Llc conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is American Organ Transplant And Cancer Research Institute Llc recruiting for clinical trials?

Yes, American Organ Transplant And Cancer Research Institute Llc currently has 2 trials that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More